Patents Assigned to IRIDEX
  • Patent number: 11058890
    Abstract: A handheld device for delivering therapeutic light toward an eye of a patient includes a device housing that is configured to be held by a user in delivering the therapeutic light, a plurality of light sources disposed within the device housing, and an array of lenses disposed near the distal end of the device housing. Each light source is configured to independently emit a beam of therapeutic light and each lens of the array is aligned with a respective light source so that each beam of therapeutic light that is emitted from the respective light sources is focused and directed by the respective lenses of the array to target tissue of the eye in order to therapeutically treat to the target tissue.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: July 13, 2021
    Assignee: Iridex Corporation
    Inventor: Howard Chen
  • Patent number: 11026860
    Abstract: Optical scanning system and method for performing therapy on trabecular meshwork of a patient's eye, including a light source for producing alignment and therapeutic light, a scanning device for deflecting the alignment and therapeutic light to produce an alignment therapeutic patterns of the alignment and therapeutic light, and an ophthalmic lens assembly for placement over a patient's eye that includes a reflective optical element for reflecting the light patterns onto the trabecular meshwork of the patient's eye. The reflective optical element can be a continuous annular mirror (e.g. smooth or with multiple facets) to image the entire trabecular meshwork, or a reflective optical element that moves in coordination with the deflection of the beam. Visualization of the alignment and therapeutic patterns of light on the eye can be implemented by reflection thereof off a visualization mirror that transmits a portion of light emanating from the trabecular meshwork.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: June 8, 2021
    Assignee: IRIDEX
    Inventors: Dan E. Andersen, David H. Mordaunt, Michael W. Wiltberger
  • Patent number: 11020612
    Abstract: A light based system for treating an eye includes a mask that is configured for positioning on the eye and a light source that is configured to deliver therapeutic light. The mask has an inner surface that is positionable against the eye and an outer surface that is opposite the inner surface. The mask is optically opaque to prevent transmission of light through the mask and the mask includes at least one transparent opening that allows transmission of light through the mask to target tissue of the eye posterior the transparent opening. The light source is positioned relative to the mask so that the delivered therapeutic light irradiates at least a portion of the mask and the transparent opening. Therapeutic light traverses through the transparent opening to the target tissue positioned posterior the transparent opening.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: June 1, 2021
    Assignee: IRIDEX Corporation
    Inventor: Howard Chen
  • Publication number: 20200352433
    Abstract: In some embodiments, an ophthalmic laser system may be provided that does not include a traditional laser console. Instead, the treatment device may be configured to house the treatment light source within the device handle. Additionally, in some embodiments, the handheld treatment device may include a user interface, such as dials and buttons, for adjusting various parameters of the therapeutic light. With certain embodiments, the self-contained handheld treatment device may be operated independent of an AC power source. For example, in some embodiments, the handheld treatment device may be battery powered. Additionally, the handheld treatment device may be disposable or may utilize replaceable distal tips in certain embodiments. Certain embodiments may be particularly designed for transscleral cyclophotocoagulation. Also, treatment guides are provided that may be configured to couple with a treatment device to align the device with a target tissue of the eye.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 12, 2020
    Applicant: IRIDEX Corporation
    Inventors: Howard Chen, David Buzawa
  • Publication number: 20200323688
    Abstract: The present invention generally relates systems, methods, and devices for treating an eye of a patient. In some embodiments, a system may be provided that includes a console for generating a treatment laser and an illumination light. The system may further include a treatment probe for delivering the illumination light to an eye so as to illuminate the ciliary process of the eye. With the illuminated ciliary process, the treatment probe may be aligned to deliver the treatment laser from the console to the ciliary process of the eye for the purpose of treating a patient for glaucoma. In some embodiments, a treatment probe may be provided with an illumination fiber for delivering light to specific portions of the eye or at desired angles in order to illuminate the ciliary process. In some embodiments a treatment probe may be configured to cooperate with a removable light pen for eye illumination.
    Type: Application
    Filed: June 29, 2020
    Publication date: October 15, 2020
    Applicant: IRIDEX Corporation
    Inventors: Steven D. Vold, Kenneth A. Peartree, David Buzawa
  • Patent number: 10758118
    Abstract: In some embodiments, an ophthalmic laser system may be provided that does not include a traditional laser console. Instead, the treatment device may be configured to house the treatment light source within the device handle. Additionally, in some embodiments, the handheld treatment device may include a user interface, such as dials and buttons, for adjusting various parameters of the therapeutic light. With certain embodiments, the self-contained handheld treatment device may be operated independent of an AC power source. For example, in some embodiments, the handheld treatment device may be battery powered. Additionally, the handheld treatment device may be disposable or may utilize replaceable distal tips in certain embodiments. Certain embodiments may be particularly designed for transscleral cyclophotocoagulation. Also, treatment guides are provided that may be configured to couple with a treatment device to align the device with a target tissue of the eye.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: September 1, 2020
    Assignee: IRIDEX Corporation
    Inventors: Howard Chen, David Buzawa
  • Patent number: 10758418
    Abstract: The present invention generally relates systems, methods, and devices for treating an eye of a patient. In some embodiments, a system may be provided that includes a console for generating a treatment laser and an illumination light. The system may further include a treatment probe for delivering the illumination light to an eye so as to illuminate the ciliary process of the eye. With the illuminated ciliary process, the treatment probe may be aligned to deliver the treatment laser from the console to the ciliary process of the eye for the purpose of treating a patient for glaucoma. In some embodiments, a treatment probe may be provided with an illumination fiber for delivering light to specific portions of the eye or at desired angles in order to illuminate the ciliary process. In some embodiments a treatment probe may be configured to cooperate with a removable light pen for eye illumination.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: September 1, 2020
    Assignees: IRIDEX Corporation
    Inventors: Steven D. Vold, Kenneth A. Peartree, David Buzawa
  • Publication number: 20200206521
    Abstract: A lens or eye mask for treating an eye of a patient includes a flexible printed circuit board (PCB) that is configured to fit over at least a portion of a surface of the eye and a plurality of electrode pairs that are arranged on the flexible PCB. An electrical source is configured to provide electrical energy to each electrode pair to create a near electromagnetic field within the eye and thereby therapeutically treat target tissue within the eye. A spacing between electrodes of each electrode pair is controlled to achieve a predetermined penetration depth of the near electromagnetic field within the eye.
    Type: Application
    Filed: December 17, 2019
    Publication date: July 2, 2020
    Applicant: IRIDEX Corporation
    Inventor: Howard Chen
  • Publication number: 20200054488
    Abstract: A treatment probe for treating an eye of a patient includes an elongate body that defines a handle and a treatment fiber that is housed within the elongate body. The treatment fiber is configured to deliver treatment light energy to the eye. A contact member is disposed on an end of the elongate body. The contact member has a contact surface for positioning on a surface of the eye, two side edges that are positioned on opposite sides of the contact surface, and a fluid channel. The contact surface conforms to the shape of the eye's sclera and the two side edges are shaped to direct fluid that is present on the surface of the eye toward the fluid channel when the contact member is moved laterally across the surface of the eye. The fluid aggregates within the fluid channel and contacts a distal end of the treatment fiber.
    Type: Application
    Filed: June 28, 2019
    Publication date: February 20, 2020
    Applicant: IRIDEX Corporation
    Inventors: Howard Chen, George Marcellino
  • Patent number: 10500094
    Abstract: Systems, devices, and methods for treating a glaucomatous eye are provided. Embodiments may provide a treatment probe for treating an eye of a patient. The treatment probe may have an elongate body with a contact surface at a distal end of the elongate body. A treatment fiber or light source may be housed in the treatment probe and may be configured to direct treatment energy from the contact surface. The contact surface may be configured to couple to a surface of the eye to deliver the energy into the target area. In many embodiments the contact surface may have a convex configuration with a rounded outer shape and edge that facilitates the sweeping of the probe surface across the eye during treatment delivery. In some embodiments the probe may be swept in arc motions while delivering treatment energy to the eye.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: December 10, 2019
    Assignees: IRIDEX Corporation, National University Hospital (Singapore) PTE LTD, National University of Singapore
    Inventors: David Buzawa, Paul T. K. Chew
  • Patent number: 10500095
    Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: December 10, 2019
    Assignee: IRIDEX Corporation
    Inventor: Kingman Yee
  • Patent number: 10369049
    Abstract: A treatment probe for treating an eye of a patient includes an elongate body that defines a handle and a treatment fiber that is housed within the elongate body. The treatment fiber is configured to deliver treatment light energy to the eye. A contact member is disposed on an end of the elongate body. The contact member has a contact surface for positioning on a surface of the eye, two side edges that are positioned on opposite sides of the contact surface, and a fluid channel. The contact surface conforms to the shape of the eye's sclera and the two side edges are shaped to direct fluid that is present on the surface of the eye toward the fluid channel when the contact member is moved laterally across the surface of the eye. The fluid aggregates within the fluid channel and contacts a distal end of the treatment fiber.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: August 6, 2019
    Assignee: IRIDEX Corporation
    Inventors: Howard Chen, George Marcellino
  • Patent number: 10292868
    Abstract: Systems, devices, and methods for treating a glaucomatous eye are provided. An amount of pulsed laser energy is delivered to the pars plana of the eye by a hand-holdable device which comprises a hand-holdable elongate member and a contact member disposed on an end of the elongate member. A contact surface of the contact member is placed in direct contact with the eye so that a reference edge of the contact member aligns with the limbus and a treatment axis defined by the elongate member is angularly offset from the optical axis of the eye. The amount of pulsed laser energy delivered is insufficient to effect therapeutic photocoagulation but is sufficient to increase uveoscleral outflow so as to maintain a reduction from pre-laser treatment intraocular pressure. Amounts of pulsed laser energy will be transmitted to a circumferential series of tissue regions of the eye.
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: May 21, 2019
    Assignees: IRIDEX Corporation, National University Hospital (Singapore), National University Hospital (Singapore) PTE LTD
    Inventors: Paul T. K. Chew, David M. Buzawa, Giorgio Dorin
  • Patent number: 10238540
    Abstract: Embodiments of the invention provide systems for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: March 26, 2019
    Assignee: IRIDEX Corporation
    Inventors: Kingman Yee, David Buzawa
  • Patent number: 10238541
    Abstract: The procedures described herein may involve using one or more treatment beams to induce one or more therapeutic benefits. In some embodiments, a series of short duration light pulses may be delivered to ocular tissue at a plurality of target locations with a thermal relaxation time delay to limit the temperature rise of the target ocular tissue and thereby limit a thermal effect to only a desired portion of the ocular tissue. The thermal relaxation time delay may be roughly equivalent to a duration of a scan of the treatment beam between each of the target locations. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered at each target location within a sufficiently short duration so as to produce a visual appearance of a treatment pattern on the ocular tissue of the patient's eye.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: March 26, 2019
    Assignee: IRIDEX Corporation
    Inventors: Kingman Yee, Ronald Avisa, Michael Miu
  • Patent number: 9857666
    Abstract: The present invention generally relates to methods and devices for mounting an image capture device to an optical viewing instrument such as a microscope, telescope, or binocular. More specifically, some embodiments of the present invention relate to an apparatus for mounting a smart phone to an observation tube of microscope. The optical viewing instrument may have an observation tube and an ocular attached thereto. The adapter may include an observation tube ring mount configured to be installed on the observation tube. An observation tube mount may be configured to engage with the installed ring mount. An image capture device holder may be configured to couple with the observation tube mount and configured to receive an image capture device. The image capture device may be a common device such as a smart phone. Optionally, a window may be included in the observation tube mount to facilitate viewing of ocular indicia.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: January 2, 2018
    Assignee: IRIDEX CORPORATION
    Inventors: Aaron Coppage, Alexander Fernandez
  • Patent number: 9707129
    Abstract: Embodiments of the invention provide systems and methods for treating the retina and/or other areas of a patient's eye. The procedures may involve using one or more treatment beams (e.g., lasers) to cause photocoagulation or laser coagulation to finely cauterize ocular blood vessels and/or prevent blood vessel growth to induce one or more therapeutic benefits. In other embodiments, a series of short duration light pulses (e.g., between 5-15 microseconds) may be delivered to the retinal tissue with a thermal relaxation time delay between the pulse to limit the temperature rise of the target retinal tissue and thereby limit a thermal effect to only the retinal pigment epithelial layer. Such procedures may be used to treat diabetic retinopathy, macular edema, and/or other conditions of the eye. The treatment beam may be delivered within a treatment boundary or pattern defined on the retina of the patient's eye.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: July 18, 2017
    Assignee: IRIDEX Corporation
    Inventor: Kingman Yee
  • Patent number: 9700461
    Abstract: Systems, devices, and methods for treating a glaucomatous eye are provided. Embodiments may provide a treatment probe for treating an eye of a patient. The treatment probe may have an elongate body with a contact surface at a distal end of the elongate body. A treatment fiber or light source may be housed in the treatment probe and may be configured to direct treatment energy from the contact surface. The contact surface may be configured to couple to a surface of the eye to deliver the energy into the target area. In many embodiments the contact surface may have a convex configuration with a rounded outer shape and edge that facilitates the sweeping of the probe surface across the eye during treatment delivery. In some embodiments the probe may be swept in arc motions while delivering treatment energy to the eye.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: July 11, 2017
    Assignees: IRIDEX Corporation, National University Hospital (Singapore) PTE Ltd, National University of Singapore
    Inventors: David Buzawa, Paul T. K. Chew
  • Patent number: 9629749
    Abstract: The present invention generally relates systems, methods, and devices for treating an eye of a patient. In some embodiments, a system may be provided that includes a console for generating a treatment laser and an illumination light. The system may further include a treatment probe for delivering the illumination light to an eye so as to illuminate the ciliary process of the eye. With the illuminated ciliary process, the treatment probe may be aligned to deliver the treatment laser from the console to the ciliary process of the eye for the purpose of treating a patient for glaucoma. In some embodiments, a treatment probe may be provided with an illumination fiber for delivering light to specific portions of the eye or at desired angles in order to illuminate the ciliary process. In some embodiments a treatment probe may be configured to cooperate with a removable light pen for eye illumination.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: April 25, 2017
    Assignee: IRIDEX Corporation
    Inventors: Steven D. Vold, Kenneth A. Peartree, David Buzawa
  • Patent number: 9307985
    Abstract: Improved tissue fasteners are disclosed that can be inserted into (and optionally through) tissue structures underlying a tissue surface for affixing overlapping tissues and tissue planes together, and the like. In some embodiments, an elongate anvil body may protrude distally and/or laterally from a fastener support disposed along the base. The anvil body may have a sharpened end and be configured to penetrate into the tissue, with the elongate anvil body optionally having a bend from a more distal orientation adjacent the clip support to a more lateral orientation adjacent the sharpened end during at least a portion of the deployment. The first leg can be driven through a desired location on the surface of the first tissue and against a receptacle of the anvil body so as to deform the fastener and affix it to the first tissue.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: April 12, 2016
    Assignee: IRIDEX Corporation
    Inventors: Steven D. Vold, Kenneth A. Peartree, Timothy D. Buckley, Aaron Feustel